Regulation of mda-7 gene expression during human melanoma differentiation
- 2 March 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (10) , 1362-1368
- https://doi.org/10.1038/sj.onc.1203424
Abstract
Induction of irreversible growth arrest and terminal differentiation in human melanoma cells following treatment with recombinant human fibroblast interferon (IFN-beta) and mezerein (MEZ) results in elevated expression of a specific melanoma differentiation associated gene, mda-7. Experiments were conducted to define the mechanism involved in the regulation of mda-7 expression in differentiating human melanoma cells. The mda-7 gene is actively transcribed in uninduced HO-1 human melanoma cells and the rate of transcription of mda-7 is not significantly enhanced by treatment with IFN-beta, MEZ or IFN-beta+MEZ. The high basal activity of the mda-7 promoter in uninduced melanoma cells and the absence of enhancing effect upon treatment with differentiation inducers is corroborated by transfection studies using the promoter region of mda-7 linked to a luciferase reporter gene containing the SV40 polyadenylation signal sequence. RT - PCR analysis detects the presence of low levels of mda-7 transcripts in uninduced and concomitant increases in differentiation inducer treated HO-1 cells. However, steady-state mda-7 mRNA is detected only in IFN-beta+MEZ and to a lesser degree in MEZ treated cells. We show that induction of terminal differentiation of HO-1 cells with IFN-beta+MEZ dramatically increases the half-life of mda-7 mRNA while treatment with cycloheximide results in detectable mda-7 mRNA in control and inducer treated cells. These observations confirm constitutive activity of the mda-7 promoter in HO-1 cells irrespective of differentiation status suggesting posttranscriptional processes as important determinants of mda-7 expression during terminal differentiation. The 3' UTR region of mda-7 contains AU-rich elements (ARE) that contribute to rapid mda-7 mRNA turnover during proliferation and reversible differentiation, a process controlled by a labile protein factor(s). Substitution of the SV40 polyadenylation signal sequence in the luciferase reporter plasmid with the mda-7-ARE-3'-UTR renders the Luciferase message unstable when expressed in proliferating and reversibly differentiated melanoma cells. In contrast, the luciferase message is stabilized when the mda-7-ARE-3'-UTR construct is expressed in terminally differentiated HO-1 cells. These results provide compelling evidence that mda-7 expression during terminal differentiation in human melanoma cells is regulated predominantly at a posttranscriptional level.Keywords
This publication has 32 references indexed in Scilit:
- Differentiation, differentiation/gene therapy and cancerPharmacology & Therapeutics, 1997
- Identification of HuR as a protein implicated in AUUUA-mediated mRNA decayThe EMBO Journal, 1997
- Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay.Genes & Development, 1991
- Characterization of a metastasis‐deficient lectin‐resistant human melanoma mutantInternational Journal of Cancer, 1989
- A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 1986
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant ProteinsScience, 1985
- Effects of Combined Treatment with Interferon and Mezerein on Melanogenesis and Growth in Human Melanoma CellsJournal of Interferon Research, 1985
- Regulation of messenger RNA stability in mouse erythroleukemia cellsJournal of Molecular Biology, 1985
- c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogeneCell, 1984
- The structure of eight distinct cloned human leukocyte interferon cDNAsNature, 1981